Managers / Q3 2020 · view latest →
KINGDON CAPITAL MANAGEMENT, L.L.C.
CIK 0001000097 · 152 WEST 57TH STREET, 50TH FLOOR, NEW YORK, NY, 10019 · 212-333-0100
Reported Value
$891M
Q3 2020
Positions
59
Filings on Record
31
2019–present window
Filed
Nov 16, 2020
original filing
Summary
Kingdon Capital Management, L.L.C. reported $891M in U.S.-listed holdings across 59 positions for Q3 2020.
Its largest position, Biohaven Pharmactl Hldg Co L, represents 9.6% of the portfolio.
Compared with Q2 2020, the fund opened 21 new positions and exited 15.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Common Stock · 62.6% · $558M
- Other · 18.2% · $162M
- ETP · 14.7% · $131M
- ADR · 4.6% · $41M
Quarter-over-Quarter Changes full breakdown →
Holdings — Q3 2020
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $911M | 67 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $841M | 68 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $806M | 77 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $743M | 67 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $945M | 67 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $702M | 70 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $902M | 79 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $933M | 82 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $916M | 83 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $797M | 74 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $868M | 72 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $1.1B | 79 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $532M | 57 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $502.2B | 50 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $782M | 60 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $589M | 69 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $959M | 82 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $870M | 77 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $822M | 62 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $863M | 68 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $979M | 62 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $925M | 56 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $891M | 59 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $1.1B | 54 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $546M | 52 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $664M | 55 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $847M | 61 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $1.0B | 68 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $748M | 61 | May 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $663M | 59 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.